Christopher M. Mahaffey

Schedule-Dependent Apoptosis in K-ras Mutant Non–Small-Cell Lung Cancer Cell Lines Treated with Docetaxel and Erlotinib: Rationale for Pharmacodynamic Separation

Christopher M. Mahaffey, Angela M. Davies, Jr Primo N. Lara et al. · Clinical Lung Cancer · 2007 · 77 citations

Medicine, Oncology, Pharmacology +14

Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma

Christopher M. Mahaffey, Hongqiao Zhang, Alessandra Rinna et al. · Free Radical Biology and Medicine · 2009 · 64 citations · Full text

Medicine, Molecular Biology, Oncology +14

Dual Blockade of PKA and NF–κB Inhibits H2 Relaxin-Mediated Castrate-Resistant Growth of Prostate Cancer Sublines and Induces Apoptosis

Ruth L. Vinall, Christopher M. Mahaffey, Ryan R. Davis et al. · Hormones and Cancer · 2011 · 37 citations · Full text

Medicine, Oncology, Pharmacology +15

Aberrant Regulation of the MRP3 Gene in Non-small Cell Lung Carcinoma

Christopher M. Mahaffey, Nichole Mahaffey, William Holland et al. · Journal of Thoracic Oncology · 2011 · 17 citations · Full text

Medicine, Molecular Biology, Oncology +10